Gynecologic Cancer
Conference Coverage
Superiority of Dose-Dense Chemo Upheld for Ovarian Cancer
Major Finding: With a median follow-up of 6.4 years, median overall survival was not reached with dose-dense paclitaxel-plus-carboplatin...
Conference Coverage
Olaparib Defers Progression of Serous Ovarian Cancer - Again
Major Finding: Addition of olaparib concurrently to paclitaxel-carboplatin chemotherapy and as maintenance therapy reduced the risk of progression...
Clinical Review
UPDATE: OVARIAN CANCER
New studies add to our understanding of which women may benefit from screening. The goal of improving overall survival among women who have this...
Clinical Review
When can MRI make the difference for you in diagnosing a gyn abnormality?
MRI shouldn’t be the first-line modality for characterizing a mass. Rather, make it your effective problem-solver when ultrasonography has left...
News for Your Practice
Is there a relationship between in vitro fertilization and breast cancer?
Not overall, although there is an increased rate of breast cancer in women who began IVF when young, a large cohort study reveals
News
Fertility Preservation No Longer Experimental for Cancer Patients
News
New Dermoscopic Insights Gleaned for Mucosal Lesions
News
Study Fine-Tunes Link Between Endometriosis, Ovarian Cancer
News
Evidence Suggests Pregnancies Can Survive Maternal Cancer Treatment
News for Your Practice
New cervical Ca screening guidelines recommend less frequent assessment
Annual assessment increases the harms of cervical cancer screening, compared with longer intervals, according to updated guidelines